Drug companies doing business abroad—and who isn't?—face a special risk of running afoul of stepped-up enforcement of anticorruption laws. Travel alert: When in Rome, don't!
Jun 1, 2007
By:
R. Christopher Cook, Jonathan B. Leiken
Compliance requires overcoming cultural barriers. To start with, in some countries the taboo against bribery is not as strong as it is here.
|
Pharma tends not to treat relationships with foreign doctors as cautiously as it does those with US physicians. But watch out: Misconduct on the part of your international employees could get kicked back onto your plate.
May 1, 2006
By:
R. Christopher Cook, Jesse A. Witten
Criminal penalties for violating the Foreign Corrupt Practices Act can be substantial. Businesses found guilty may be fined upwards of $2.5 million for each offense, or twice the amount gained as a result of the violation.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
